Peer-Reviewed Publication Hefei Institutes of Physical Science, Chinese Academy of Sciences FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Supplementary coverview more Credit: GE Dianlong A research team led by Prof. CHU Yannan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in lung cancer...
Tag: <span>Lung cancer</span>
Weakness in lung cancer’s defenses found—an enzyme that boosts cancer cell metabolism
by Catherine Caruso, Harvard Medical School A microscope image of lung cancer cells (purple) containing the activated form of a metabolic enzyme called GUK1 (brown) that supports cancer growth. Credit: Haigis lab Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable...
Air pollution drives lung cancer surge in non-smokers, study reveals
Credit: Unsplash/CC0 Public Domain Air pollution is fueling a rise in the commonest form of lung cancer among non-smokers, hitting women and people in southeast Asia particularly hard, according to a study published on Tuesday. Lung cancer is the commonest form of the disease, with 2.5 million people diagnosed in 2022, said the study, published in the Lancet...
Small cell lung cancer: Facts about the disease
by Hunter Boyce Credit: Pixabay/CC0 Public Domain There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small cell lung cancer is often categorized in one of two stages: limited or extensive. “If your cancer is limited stage, you might get radiation or chemotherapy (chemo) treatments...
Lung cancer trial reveals 40% drop in deaths using biomarker testing
by University of St Andrews Credit: Pixabay/CC0 Public Domain New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths. This study, conducted with 12,000 smokers and ex-smokers, demonstrates how biomarkers—measurable indicators of biological changes—can identify individuals...
Tumor DNA in the blood can predict lung cancer outcome
Peer-Reviewed Publication The Francis Crick Institute Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study. Circulating tumour DNA (ctDNA) is fragments of DNA released into the blood by tumours. It’s known to be...
Repurposed drug has promising efficacy in non-small cell lung cancer
by UT Southwestern Medical Center UT Southwestern researchers (l-r) Farjana Fattah, Ph.D., Mitchell S. von Itzstein, M.D., David E. Gerber, M.D., and Kelly Kyle, B.S., discovered a drug that shows promise in treating non-small cell lung cancer with KRAS mutations. Credit: UT Southwestern Medical Center An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in...
Cambridge researchers develop urine test for early detection of lung cancer
Cambridge scientists have developed a urine test for early detection of lung cancer. The test, the first of its kind, detects ‘zombie’ cells that could indicate the first signs of the disease. Researchers hope that early detection, through the simple urine test, could enable earlier treatment interventions, significantly improving patient outcomes and prognosis. Around 36,600...
Fibroblastic reticula cells can organize T cells in the fight against lung cancer
by Justin Jackson , Medical Xpress Graphical abstract. Credit: Cell (2024). DOI: 10.1016/j.cell.2024.10.042 Institute of Immunobiology-led research has made a significant breakthrough in understanding how the body combats lung cancer. Their study reveals that specific cells, known as fibroblastic reticular cells (FRCs), create environments within tumors that help protect and activate immune cells to fight the cancer...
Gene activation linked to severity of a rare lung cancer
October 2, 2024by University of Cologne ERT expression and telomerase activity in pulmonary carcinoids. Credit: Journal of Clinical Oncology (2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are rare tumors of the lung with extremely different clinical courses. In many patients, they behave like benign tumors; surgical removal of the tumor leads to a complete cure. However, some patients...